Several preclinical studies have shown that the blockade of TLR2 significantly inhibited the production of pro-inflammatory cytokines TNF-α, IL-1β, and IL-6 in cultured synoviocytes from RA patients [62]. Here, IL6 is linked to rheumatoid arthritis.